- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
EndoSonics wins clearance for Trak Back
Intravascular ultrasound developer EndoSonics has received Food and Drug Administration clearance for its disposable pull back device, Trak Back. The device allows users to control EndoSonics’ intravascular ultrasound (IVUS) imaging catheters, thus
Intravascular ultrasound developer EndoSonics has received Food and Drug Administration clearance for its disposable pull back device, Trak Back. The device allows users to control EndoSonics intravascular ultrasound (IVUS) imaging catheters, thus facilitating both 3-D-like images and cross-sectional displays. Trak Back was designed for use with EndoSonicss Oracle ultrasound systems and Visions Five-64 series of ultrasound catheters.
The device is automated, which the Rancho Cordova, CA, company believes will make it easier to use than competitive IVUS products that are mechanical. Trak Back is part of EndoSonicss strategy to provide its customers with IVUS-guided stenting products by combining its catheters with therapeutic devices. EndoSonics expects to begin shipping Trak Back by the end of the third quarter 1999.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
